$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | SGMO | SANGAMO THERAPEUTI ... | Fontenot Jason D. | SVP, Chief Scientif ... | Payment of Exercise | F | 11.71 | 811 | 9,497 | 62,496 | 63.3 K to 62.5 K (-1.28 %) |
| Apr 27 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP, PFO and PAO | Payment of Exercise | F | 11.71 | 662 | 7,752 | 40,128 | 40.8 K to 40.1 K (-1.62 %) |
| Apr 27 2021 | SGMO | SANGAMO THERAPEUTI ... | Fontenot Jason D. | SVP, Chief Scientif ... | Payment of Exercise | F | 11.71 | 811 | 9,497 | 62,496 | 63.3 K to 62.5 K (-1.28 %) |
| Apr 27 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP, PFO and PAO | Payment of Exercise | F | 11.71 | 662 | 7,752 | 40,128 | 40.8 K to 40.1 K (-1.62 %) |
| Mar 29 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP, PFO and PAO | Payment of Exercise | F | 12.27 | 345 | 4,233 | 40,790 | 41.1 K to 40.8 K (-0.84 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | M | 11.02 | 11,981 | 132,031 | 238,019 | |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.17 | 543 | 7,152 | 83,238 | 83.8 K to 83.2 K (-0.65 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.18 | 5,000 | 65,901 | 83,781 | 88.8 K to 83.8 K (-5.63 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.10 | 11,981 | 156,989 | 88,781 | 100.8 K to 88.8 K (-11.89 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Buy | M | 11.02 | 11,981 | 132,031 | 100,762 | 88.8 K to 100.8 K (+13.50 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Option Exercise | A | 11.19 | 27,500 | 307,725 | 27,500 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Grant | A | 0.00 | 13,750 | 0 | 41,135 | 27.4 K to 41.1 K (+50.21 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Payment of Exercise | F | 11.19 | 1,863 | 20,847 | 27,385 | 29.2 K to 27.4 K (-6.37 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Option Exercise | A | 11.19 | 80,000 | 895,200 | 80,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Grant | A | 0.00 | 40,000 | 0 | 98,199 | 58.2 K to 98.2 K (+68.73 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Payment of Exercise | F | 11.19 | 7,779 | 87,047 | 58,199 | 66 K to 58.2 K (-11.79 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Option Exercise | A | 11.19 | 80,000 | 895,200 | 80,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Grant | A | 0.00 | 40,000 | 0 | 140,000 | 100 K to 140 K (+40.00 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 11.19 | 88,000 | 984,720 | 88,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Grant | A | 0.00 | 44,000 | 0 | 88,781 | 44.8 K to 88.8 K (+98.26 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Payment of Exercise | F | 11.19 | 5,762 | 64,477 | 44,781 | 50.5 K to 44.8 K (-11.40 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Option Exercise | A | 11.19 | 276,750 | 3,096,833 | 276,750 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Grant | A | 0.00 | 138,375 | 0 | 347,066 | 208.7 K to 347.1 K (+66.31 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 11.19 | 35,311 | 395,130 | 208,691 | 244 K to 208.7 K (-14.47 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 8,200 | 0 | 48,200 | 40 K to 48.2 K (+20.50 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 8,200 | 0 | 25,700 | 17.5 K to 25.7 K (+46.86 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 8,200 | 0 | 31,200 | 23 K to 31.2 K (+35.65 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Grant | A | 0.00 | 8,200 | 0 | 13,200 | 5 K to 13.2 K (+164.00 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Jan 26 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 14.95 | 3,977 | 59,456 | 244,002 | 248 K to 244 K (-1.60 %) |
| Jan 06 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Sell | S | 16.74 | 2,464 | 41,247 | 65,978 | 68.4 K to 66 K (-3.60 %) |
| Dec 30 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Sell | S | 18.13 | 3,331 | 60,391 | 68,442 | 71.8 K to 68.4 K (-4.64 %) |
| Dec 18 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | M | 5.99 | 10,000 | 59,900 | 0 | |
| Dec 18 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Sell | S | 13.27 | 10,000 | 132,747 | 15,000 | 25 K to 15 K (-40.00 %) |
| Dec 18 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Buy | M | 5.99 | 10,000 | 59,900 | 25,000 | 15 K to 25 K (+66.67 %) |
| Sep 11 2020 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Option Exercise | A | 10.43 | 30,000 | 312,900 | 30,000 | |
| Sep 11 2020 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jul 31 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | E | 0.00 | 1 | 0 | 1 | |
| Jul 31 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | E | 0.00 | 1 | 0 | 2 | |
| Jun 29 2020 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Option Exercise | A | 9.16 | 200,000 | 1,832,000 | 200,000 | |
| Jun 29 2020 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | M | 2.09 | 1 | 2 | 2 | |
| Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Sell | D | 11.23 | 14,907 | 167,406 | 70,116 | 85 K to 70.1 K (-17.53 %) |
| Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Buy | M | 0.00 | 14,907 | 0 | 85,023 | 70.1 K to 85 K (+21.26 %) |
| Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | M | 2.09 | 1 | 2 | 2 | |
| Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Sell | D | 11.23 | 14,907 | 167,406 | 70,116 | 85 K to 70.1 K (-17.53 %) |
| Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Buy | M | 0.00 | 14,907 | 0 | 85,023 | 70.1 K to 85 K (+21.26 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 2,500 | 0 | 32,500 | 30 K to 32.5 K (+8.33 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 2,500 | 0 | 15,500 | 13 K to 15.5 K (+19.23 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Apr 28 2020 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Payment of Exercise | F | 8.32 | 647 | 5,383 | 26,603 | 27.3 K to 26.6 K (-2.37 %) |
| Mar 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Grant | A | 0.00 | 3,000 | 0 | 27,250 | 24.3 K to 27.3 K (+12.37 %) |
| Mar 20 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Option Exercise | M | 5.42 | 35,000 | 189,700 | 0 | |
| Mar 20 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Sell | S | 6.00 | 35,000 | 210,000 | 5,000 | 40 K to 5 K (-87.50 %) |
| Mar 20 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Buy | M | 5.42 | 35,000 | 189,700 | 40,000 | 5 K to 40 K (+700.00 %) |
| Mar 19 2020 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Buy | P | 5.20 | 3,000 | 15,585 | 13,000 | 10 K to 13 K (+30.00 %) |
| Mar 19 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Buy | P | 4.99 | 5,000 | 24,950 | 30,000 | 25 K to 30 K (+20.00 %) |
| Mar 18 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Option Exercise | M | 5.42 | 15,000 | 81,300 | 35,000 | |
| Mar 18 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Sell | S | 6.02 | 15,000 | 90,261 | 5,000 | 20 K to 5 K (-75.00 %) |
| Mar 18 2020 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Buy | M | 5.42 | 15,000 | 81,300 | 20,000 | 5 K to 20 K (+300.00 %) |
| Mar 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Buy | P | 5.67 | 5,000 | 28,350 | 25,000 | 20 K to 25 K (+25.00 %) |
| Mar 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Buy | P | 6.31 | 15,000 | 94,650 | 20,000 | 5 K to 20 K (+300.00 %) |
| Feb 27 2020 | SGMO | SANGAMO THERAPEUTI ... | Woolfson Adrian | EVP Research & Deve ... | Option Exercise | A | 6.80 | 100,000 | 680,000 | 100,000 | |
| Feb 27 2020 | SGMO | SANGAMO THERAPEUTI ... | Woolfson Adrian | EVP Research & Deve ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Option Exercise | A | 6.80 | 33,000 | 224,400 | 33,000 | |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Grant | A | 0.00 | 16,500 | 0 | 22,250 | 5.8 K to 22.3 K (+286.96 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Option Exercise | A | 6.80 | 110,000 | 748,000 | 110,000 | |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Grant | A | 0.00 | 55,000 | 0 | 69,128 | 14.1 K to 69.1 K (+389.30 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Payment of Exercise | F | 6.80 | 1,703 | 11,580 | 14,128 | 15.8 K to 14.1 K (-10.76 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 6.80 | 100,000 | 680,000 | 100,000 | |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Grant | A | 0.00 | 500,000 | 0 | 50,000 | -450,000 to 50 K (-111.11 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Lee Sung | EVP, Chief Financia ... | Option Exercise | A | 6.80 | 100,500 | 683,400 | 100,500 | |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Lee Sung | EVP, Chief Financia ... | Grant | A | 0.00 | 50,000 | 0 | 93,750 | 43.8 K to 93.8 K (+114.29 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | A | 6.80 | 110,000 | 748,000 | 110,000 | |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Grant | A | 0.00 | 55,000 | 0 | 70,116 | 15.1 K to 70.1 K (+363.85 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Payment of Exercise | F | 6.80 | 2,384 | 16,211 | 15,116 | 17.5 K to 15.1 K (-13.62 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Option Exercise | A | 6.80 | 337,500 | 2,295,000 | 337,500 | |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Grant | A | 0.00 | 168,750 | 0 | 247,979 | 79.2 K to 248 K (+212.99 %) |
| Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 6.80 | 7,264 | 49,395 | 79,229 | 86.5 K to 79.2 K (-8.40 %) |
| Feb 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Option Exercise | A | 7.60 | 30,000 | 228,000 | 30,000 | |
| Feb 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Feb 03 2020 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 11.02 | 250,000 | 2,755,000 | 250,000 | |
| Jan 28 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 7.50 | 4,283 | 32,123 | 86,493 | 90.8 K to 86.5 K (-4.72 %) |
| Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 9.81 | 30,000 | 294,300 | 30,000 | |
| Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Lee Sung | EVP, Chief Financia ... | Option Exercise | A | 10.35 | 262,000 | 2,711,700 | 262,000 | |
| Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Lee Sung | EVP, Chief Financia ... | Grant | A | 0.00 | 43,750 | 0 | 43,750 | 0 to 43.8 K |
| Aug 14 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strat. & ... | Option Exercise | M | 2.37 | 1 | 2 | 3 | |
| Aug 14 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strat. & ... | Sell | D | 11.23 | 11,137 | 125,069 | 17,500 | 28.6 K to 17.5 K (-38.89 %) |
| Aug 14 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strat. & ... | Buy | M | 0.00 | 11,137 | 0 | 28,637 | 17.5 K to 28.6 K (+63.64 %) |
| Aug 14 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strat. & ... | Option Exercise | J | 0.00 | 4 | 0 | 4 | |
| Aug 14 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strat. & ... | Option Exercise | J | 0.00 | 4 | 0 | 4 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| May 17 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Option Exercise | M | 4.55 | 5,000 | 22,750 | 125,000 | |
| May 17 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Sell | S | 10.00 | 5,000 | 50,000 | 25,512 | 30.5 K to 25.5 K (-16.39 %) |
| May 17 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Buy | M | 4.55 | 5,000 | 22,750 | 30,512 | 25.5 K to 30.5 K (+19.60 %) |
| Apr 16 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Option Exercise | M | 4.55 | 5,000 | 22,750 | 130,000 | |
| Apr 16 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Sell | S | 12.11 | 5,000 | 60,550 | 25,512 | 30.5 K to 25.5 K (-16.39 %) |
| Apr 16 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Buy | M | 4.55 | 5,000 | 22,750 | 30,512 | 25.5 K to 30.5 K (+19.60 %) |
| Mar 18 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Option Exercise | M | 4.55 | 5,000 | 22,750 | 135,000 | |
| Mar 18 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Sell | S | 10.00 | 5,000 | 50,000 | 25,512 | 30.5 K to 25.5 K (-16.39 %) |
| Mar 18 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Buy | M | 4.55 | 5,000 | 22,750 | 30,512 | 25.5 K to 30.5 K (+19.60 %) |
| Mar 05 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Option Exercise | M | 4.55 | 5,000 | 22,750 | 140,000 | |
| Mar 05 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Sell | S | 10.00 | 5,000 | 50,000 | 25,512 | 30.5 K to 25.5 K (-16.39 %) |
| Mar 05 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Buy | M | 4.55 | 5,000 | 22,750 | 30,512 | 25.5 K to 30.5 K (+19.60 %) |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Woolfson Adrian | EVP, Research and D ... | Option Exercise | A | 9.03 | 250,000 | 2,257,500 | 250,000 | |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corporate Stra ... | Option Exercise | A | 9.03 | 105,000 | 948,150 | 105,000 | |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corporate Stra ... | Grant | A | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Turner Heather D | EVP, General Counse ... | Option Exercise | A | 9.03 | 115,500 | 1,042,965 | 115,500 | |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Turner Heather D | EVP, General Counse ... | Grant | A | 0.00 | 19,250 | 0 | 19,250 | 0 to 19.3 K |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Option Exercise | A | 9.03 | 115,500 | 1,042,965 | 115,500 | |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | EVP & Chief Financi ... | Grant | A | 0.00 | 19,250 | 0 | 25,512 | 6.3 K to 25.5 K (+307.41 %) |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Option Exercise | A | 9.03 | 379,500 | 3,426,885 | 379,500 | |
| Feb 27 2019 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Grant | A | 0.00 | 63,250 | 0 | 90,776 | 27.5 K to 90.8 K (+229.78 %) |
| Jan 28 2019 | SGMO | SANGAMO THERAPEUTI ... | Conner Edward R. | Sr. VP & Chief Medi ... | Payment of Exercise | F | 11.10 | 834 | 9,257 | 11,291 | 12.1 K to 11.3 K (-6.88 %) |
| Jan 28 2019 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | SVP & Chief Financi ... | Payment of Exercise | F | 11.10 | 988 | 10,967 | 6,262 | 7.3 K to 6.3 K (-13.63 %) |
| Jan 28 2019 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 11.10 | 3,974 | 44,111 | 27,526 | 31.5 K to 27.5 K (-12.62 %) |